GSK
903 hedge funds and large institutions have $13.3B invested in GSK in 2024 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 324 increasing their positions, 298 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
903
Holders Change
+14
Holders Change %
+1.57%
% of All Funds
13.09%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.2%
New
97
Increased
324
Reduced
298
Closed
76
Calls
$195M
Puts
$109M
Net Calls
+$86.2M
Net Calls Change
-$36.9M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$199M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$116M |
| 3 |
Millennium Management
New York
|
-$61.6M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$58M |
| 5 |
MIS
Morningstar Investment Services
Chicago,
Illinois
|
-$54.8M |
